financetom
Business
financetom
/
Business
/
Eos Energy, FlexGen Team Up to Launch Battery Energy Storage System
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eos Energy, FlexGen Team Up to Launch Battery Energy Storage System
Dec 19, 2024 8:08 AM

10:49 AM EST, 12/19/2024 (MT Newswires) -- Eos Energy Enterprises ( EOSE ) and FlexGen Power Systems said Thursday they have signed an agreement to develop and launch a battery energy storage system product that will combine Eos' Z3 batteries with FlexGen's HybridOS energy management system.

The US-made product will target utilities, independent power producers, and energy consumers, the companies said.

Financial details weren't provided.

Eos shares were up 8.2% in recent trading.

Price: 4.37, Change: +0.33, Percent Change: +8.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hitachi agrees to acquire German data and AI services firm synvert to accelerate Agentic AI and Physical AI development, driving global expansion of HMAX business
Hitachi agrees to acquire German data and AI services firm synvert to accelerate Agentic AI and Physical AI development, driving global expansion of HMAX business
Sep 23, 2025
Strengthening GlobalLogic's data and consulting capabilities and expanding footprint in Europe and the Middle East SANTA CLARA, Calif. and MÜNSTER, Germany and TOKYO, Sept. 23, 2025 /PRNewswire/ -- Hitachi, Ltd. ( HTHIF ) is advancing the realization of a Harmonized Society where environment, wellbeing, and economic growth coexist in balance.  As One Hitachi, the company is strengthening its portfolio to...
EXPLAINER-Why is leucovorin being considered as an autism treatment?
EXPLAINER-Why is leucovorin being considered as an autism treatment?
Sep 23, 2025
(Adds detail about GSK in paragraph 3) By Nancy Lapid Sept 23 (Reuters) - On Monday, the U.S. Food and Drug Administration published a notice to the Federal Register ahead of a speech by President Donald Trump, approving a version of leucovorin made by GlaxoSmithKline that the company had previously withdrawn from the FDA's consideration when it stopped manufacturing the...
AvePoint Insider Sold Shares Worth $31,468,973, According to a Recent SEC Filing
AvePoint Insider Sold Shares Worth $31,468,973, According to a Recent SEC Filing
Sep 23, 2025
03:43 AM EDT, 09/23/2025 (MT Newswires) -- Tianyi Jiang, Director, Chief Executive Officer, on September 18, 2025, sold 2,068,966 shares in AvePoint ( AVPT ) for $31,468,973. Following the Form 4 filing with the SEC, Jiang has control over a total of 13,841,853 common shares of the company, with 13,841,853 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1777921/000143774925029638/xslF345X05/rdgdoc.xml ...
BRIEF-RTW Biotech Annonuces Biogen To Acquire Alcyone Therapeutics
BRIEF-RTW Biotech Annonuces Biogen To Acquire Alcyone Therapeutics
Sep 23, 2025
Sept 23 (Reuters) - RTW Biotech Opportunities Ltd ( RTWFF ) : * RTW BIOTECH OPP. - BIOGEN TO ACQUIRE ALCYONE THERAPEUTICS * RTW BIOTECH OPPORTUNITIES LTD ( RTWFF ) - BIOGEN TO PAY $85 MILLION UPFRONT FOR ALCYONE Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved